We acknowledge that the UBC Vancouver campus is situated on the traditional, ancestral, and unceded territory of the xʷməθkʷəy̓əm (Musqueam).
Professor, PhD
Monika Naus is the Medical Director of the Communicable Diseases & Immunization Service, and the Head of Vaccine Preventable Diseases & Immunization Programs at the British Columbia Centre for Disease Control.
Dr. Naus obtained her medical training at the University of Alberta and her training in Public Health and Preventive Medicine at the University of Toronto. She then served as a federal field epidemiologist with the Laboratory Centre for Disease Control prior to starting her career in public health, with a focus on communicable disease prevention and control. Before joining BCCDC in July 2001, she was the provincial epidemiologist in Ontario from 1997 to 2001, and a senior medical consultant in vaccine preventable diseases and TB control for the Ontario Ministry of Health and Long-Term Care from 1990 to 1997.
She has been active in immunization at the national level, including on the Canadian National Advisory Committee on Immunization, which she chaired from 2003 to 2007 after being a member for eight years, and is a member of several NACI expert groups and liaison representative from the Canadian Immunization Committee. She currently co-chairs the Canadian Immunization Committee, and is a member of the Canadian Immunization Registries and Coverage Network, co-chair of the Automated Identification of Vaccine Products Working Group, member of the Canadian Immunization Research Network and involved in other national and provincial committees. She is a Fellow of the Royal College of Physicians of Canada and of the American College of Preventive Medicine.
Research:
Dr. Naus’ clinical and research interests include planning and evaluation of old and new immunization policy and programs, various aspects of vaccine preventable diseases and implications for future control in the context of immunization, immunization registries, determinants of vaccine uptake and vaccine safety.